Qi Lanlin, Wu Yuchen, Zhang Bin, Zhou Yan, He Lin, Zhang Min, Wang Kemin, Chen Mingjian, He Xiaoxiao
State Key Laboratory of Chemo and Biosensing, College of Biology, College of Chemistry and Chemical Engineering, Hunan University, Key Laboratory for Bio-Nanotechnology and Molecule Engineering of Hunan Province, Changsha 410082, China.
ACS Appl Mater Interfaces. 2025 Jul 23;17(29):41781-41791. doi: 10.1021/acsami.5c09210. Epub 2025 Jul 9.
The aptamer-based strategy for selective protein degradation demonstrates broad application prospects in the field of biomedicine, particularly holding significant therapeutic potential for tumors and other protein dysregulation-related diseases. However, it faces substantial challenges due to on-target off-tumor effects arising from nonspecific expression of target proteins. To address this issue efficiently, we report here a pH-responsive allosteric DNA nanorobot (named A/I) that enhances the precision of aptamer-mediated target protein degradation through tumor microenvironment-specific activation. The allosteric nanorobot is comprised of two modules: the recognition module (A-strand) and the response module (I-strand). To be specific, the A-strand integrates both target recognition and degradation-inducing capabilities, while the I-strand blocks the recognition sites of the A-strand through complementary base pairing and confers pH sensitivity. Under physiological pH conditions, the A/I nanorobot exists stably in the form of a double-stranded structure. When the acidic tumor microenvironment is encountered, the pH-triggered conformational change of the I-strand induces the duplex disassembly, releasing the A-strand, which can specifically bind to the target protein and subsequently induce its degradation. Our findings demonstrate that the activatable allosteric nanorobot achieves targeted protein degradation, significantly inhibiting the proliferative and migratory abilities of tumor cells. In general, the activatable allosteric nanorobot has innovatively overcome the bottleneck of insufficient selectivity in traditional aptamer-based protein degradation strategies, providing a molecular tool for precision tumor therapy technologies. In addition, the allosteric nanorobot features a simple design and enables specific degradation of diverse target proteins by flexible replacement of the recognition module, demonstrating significant potential for constructing a universal protein precise degradation platform.
基于适配体的选择性蛋白质降解策略在生物医药领域展现出广阔的应用前景,尤其在肿瘤及其他与蛋白质失调相关疾病的治疗方面具有巨大的治疗潜力。然而,由于靶蛋白的非特异性表达导致的脱靶效应,该策略面临着巨大挑战。为有效解决这一问题,我们在此报告一种pH响应型变构DNA纳米机器人(命名为A/I),它通过肿瘤微环境特异性激活来提高适配体介导的靶蛋白降解的精准度。该变构纳米机器人由两个模块组成:识别模块(A链)和响应模块(I链)。具体而言,A链整合了靶标识别和诱导降解的能力,而I链通过互补碱基配对阻断A链的识别位点并赋予pH敏感性。在生理pH条件下,A/I纳米机器人以双链结构稳定存在。当遇到酸性肿瘤微环境时,I链的pH触发构象变化诱导双链解离,释放出A链,A链可特异性结合靶蛋白并随后诱导其降解。我们的研究结果表明,这种可激活的变构纳米机器人实现了靶向蛋白质降解,显著抑制了肿瘤细胞的增殖和迁移能力。总体而言,这种可激活的变构纳米机器人创新性地克服了传统基于适配体的蛋白质降解策略中选择性不足的瓶颈,为精准肿瘤治疗技术提供了一种分子工具。此外,该变构纳米机器人设计简单,通过灵活替换识别模块能够实现多种靶蛋白的特异性降解,在构建通用蛋白质精准降解平台方面展现出巨大潜力。